Subscribe to Newsletter

Stephen T. Colgan

The Power List 2016

Stephen T. Colgan

Senior Director, Global CMC, Pfizer Worldwide Research and Development

Dr. Colgan has advocated lean stability strategies for more than a decade. These strategies provide a focus on the highest risk attributes and time points and facilitate rapid introduction of medicines into clinical trials. Regulatory filings are more science and risk-based without impacting safety, efficacy, or quality of the product.

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine